Our current results with GSTO1-1 deficient mice showing increased clinical severity of colitis, increased escape of bacteria from the colon and increased epithelial cell replication indicate that GSTO1-1 deficient mice follow a similar clinical course in the DSS colitis model to that occurring in TLR4 and MyD88 deficient mice. The gene discussed is MYD88; the disease is colitis.